Technology: Potential Applications of Monoclonal Antibodies in Cancer Diagnosis and Therapy

References

• Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495–497
   PubMed Web of Science ®Google Scholar
• Stone M J. Monoclonal antibodies in cancer. Oncology Times 1982; 6: 2
   Google Scholar
• Neville A M, Foster C S, Moshakis V, et al. Monoclonal antibodies and human tumor pathology. Human Pathol 1982; 13: 1067–1081
   PubMed Web of Science ®Google Scholar
• Borowitz M J, Stein R B. Diagnostic applications of monoclonal antibodies to human cancer. Arch Pathol Lab Med 1984; 108: 101–105
   PubMed Web of Science ®Google Scholar
• Lehninger A L. Biochemistry: Proteins and Their Biological Functions. Worth Publishers, New York 1970; 56–66
   Google Scholar
• Goding J W. Antibody production by hybridomas. J Immunol Methods 1980; 39: 285–308
   PubMed Web of Science ®Google Scholar
• Kennett J W. Hybridomas: A new dimension in biological analyses. In Vitro 1981; 17: 1036–1050
   PubMedGoogle Scholar
• Yelton D E, Shariff M D. Monoclonal antibodies: A powerful tool in biology and medicine. Ann Rev Biochem 1981; 50: 657–680
   PubMed Web of Science ®Google Scholar
• Grant A G, Duke D. Production of antibodies against antigen released from human pancreatic tumor xenografts. Br J Cancer 1981; 44: 388–395
   PubMed Web of Science ®Google Scholar
• Gusterson B A, Warburton M J, Michell D, et al. Distribution of myoepithelial cells and basement membrane proteins in the normal, benign and malignant breast. Cancer Res 1982; 42: 4763–4770
   PubMed Web of Science ®Google Scholar
• Black P H. Shedding from the cell surface of normal and cancer cells. Adv Cancer Res 1980; 32: 75–199
   PubMedGoogle Scholar
• Frankel A E, Rouse R V, Herzenberg L A. Human prostate specific and shared differentiation antigen defined by monoclonal antibodies. Proc Natl Acad Sci USA 1982; 79: 903–907
   PubMed Web of Science ®Google Scholar
• Larrick J W, Buck D. Practical aspects of human monoclonal antibody production. Biotech Jan/Feb 6–14, 1984
   Google Scholar
• Haspel M V, Hoover H G, McCabe R P, et al. Human colorectal cancer: generation of human monoclonal antibodies. Proc Am Assoc Cancer Res 1984; 25: 236
   Web of Science ®Google Scholar
• Kan-Mitchell J., Imam A, Kempf R, et al. Human monoclonal antibodies with anti-melanoma activities. Proc Am Assoc Cancer Res 1984; 25: 265
   Google Scholar
• Cote R T, Morrissey D M, Oettgen H F, et al. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer. Fed Proc 1984; 43: 2465–2469
   PubMedGoogle Scholar
• Galfre G, Milstein C, Wright B. RatXrat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG. Nature 1979; 277: 131–133
   PubMed Web of Science ®Google Scholar
• Zimmermann U, Scheurich P, Pilwat G, et al. Cells with manipulated functions: New perspectives for cell biology, medicine and technology. Angew Chem 1981; 20: 325–344
   Web of Science ®Google Scholar
• Zimmermann U, Vienken J. Electric field-induced cell-to-cell fusion. J Membrane Biol 1982; 67: 165–182
   PubMed Web of Science ®Google Scholar
• Olsson L, Kaplan H S. Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity. Proc Natl Acad Sci USA 1980; 77: 5429–5431
   PubMed Web of Science ®Google Scholar
• Bischoff R, Eisert R M, Schedel I, et al. Human hybridoma cells produced by electro-fusion. FEBS Letters 1982; 147: 64–68
   PubMed Web of Science ®Google Scholar
• Horejsi V, Hilgert I. Nitrocellulose membrane as an antigen or antibody carrier for screening hybridoma cultures. J Immunol Methods 1983; 62: 325–329
   PubMed Web of Science ®Google Scholar
• Locker D, Motta G. Detection of antibody secreting hybridomas with diazobenzyloxymethyl paper. J Immunol Methods 1983; 59: 269–275
   PubMed Web of Science ®Google Scholar
• Dangl J L, Herzenberg L A. Selection of hybridomas and hybridoma variants using the fluorescence activated cell sorter. J Immunol Methods 1982; 52: 1–14
   PubMed Web of Science ®Google Scholar
• David G S, Wang R, Bartholomew R, et al. The hybridoma- an immunochemical laser. Clin Chem 1981; 27: 1580–1585
   PubMed Web of Science ®Google Scholar
• Hybridoma Cloning News. Microencapsulation technique of purifying monoclonals. J Immunol Methods 1982; 52: 268
   Google Scholar
• Orr T. Cellular enhancer technology is key feature of Damon's culture facility. Gen Eng News Sept 12–13, 1984
   Google Scholar
• Hedin A, Carlson L, Berglund A, et al. A monoclonal antibody-enzyme immunoassay for serum carcinoembryonic antigen with increased specificity for carcinomas. Proc Natl Acad Sci USA 1983; 80: 3470–3474
   PubMed Web of Science ®Google Scholar
• Bellet D H, Wands J R, Isselbacher K J, et al. Serum a-fetoprotein levels in human disease: Perspective from a highly specific monoclonal radioimmunoassay. Proc Natl Acad Sci USA 1984; 81: 3869–3873
   PubMed Web of Science ®Google Scholar
• Lin M F, Lee C L, Chu T M. Simple assay for serum prostatic acid phosphatase with specific monoclonal antibody. Clin Chim Acta 1983; 130: 263–267
   PubMed Web of Science ®Google Scholar
• DelVillano B C, Brennan S, Brock P, et al. Radioimmunome-tric assay for a monoclonal antibody-defined tumor marker CA 19–9. Clin Chem 1983; 29: 549–552
   PubMed Web of Science ®Google Scholar
• Bast R C, Klug T L, St John E, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. New Engl J Med 1983; 309: 883–887
   PubMed Web of Science ®Google Scholar
• Ashall F, Bramwell M E, Harris H. A new marker for human cancer cells. The CA antigen and Cal antibody. Lancet 1982; 11: 1–6
   Google Scholar
• Chu T M. An introduction to radioimmunoassay. Am Soc Clin Pathol 1971; 55–69
   PubMedGoogle Scholar
• Sevier E D, David G S, Martinis J, et al. Monoclonal antibody in clinical immunology. Clin Chem 1981; 27: 1797–1806
   PubMed Web of Science ®Google Scholar
• Jensen E V. Hormone dependency of breast cancer. Cancer 1982; 47: 2319–2326
   Web of Science ®Google Scholar
• Ehrlich P H, Moyle W R, Moustafa Z A, et al. Mixing two monoclonal antibodies yields enhanced affinity for antigen. J Immunol 1982; 128: 2709–2713
   PubMed Web of Science ®Google Scholar
• Papsidero L D, Nemoto T, Croghan G A, et al. Expression of ductal carcinoma antigen in breast cancer sera as defined by using monoclonal antibody F36/22. Cancer Res 1984; 44: 4653–4657
   PubMed Web of Science ®Google Scholar
• Thomson D, Krupey J., Freedman S, et al. The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system. Proc Natl Acad Sci USA 1969; 64: 161–167
   PubMed Web of Science ®Google Scholar
• Burtin P, Chu T M, Gold P, et al. Carcinoembryonic antigen. Scand J Immunol 1979; 8: 27–38
   Google Scholar
• Wang M C, Valenzuela L A, Murphy G P, et al. Purification of a human prostate specific antigen. Invest Urol 1979; 17: 159–163
   PubMedGoogle Scholar
• Chu T M, Wang M C, Scott W W, et al. Immunochemical detection of serum prostatic acid phosphatase. Invest Urol 1978; 15: 319–323
   PubMedGoogle Scholar
• Herberman R B. Immunological approach to the biochemical markers for cancer. Biochemical Markers for Cancer, T M Chu. Marcel Dekker, New York 1982; 1–24
   Google Scholar
• Sell S. Diagnostic applications of alpha-fetoprotein. Human Pathol 1981; 11: 959–963
   Google Scholar
• Hirai H. Alpha-fetoprotein. Biochemical Markers for Cancer, T M Chu. Marcel Dekker, New York 1982; 25–60
   Google Scholar
• Lehmann F G, Wegener T. Etiology of human liver cancer: Controlled prospective study in liver cirrhosis. J Toxicol Environ Health 1979; 5: 281–299
   PubMed Web of Science ®Google Scholar
• Klesing V J, Watson R A. A closer look at serum prostatic acid phosphatase as screening test. Urology 1980; 16: 242–244
   PubMed Web of Science ®Google Scholar
• Albrechtsen R, Bagshawe K D, Buffe D, et al. Clinical use of A.F.P. and H.G.G. in testicular tumors of germ-cell origin. Lancet 1979; 11: 1042
   Google Scholar
• Kuriyama M, Wang M C, Lee C L, et al. Multiple marker evaluation of prostate cancer using tissue specific antigens. J Natl Cancer Inst 1981; 68: 99–105
   Web of Science ®Google Scholar
• Holmgren J, Lindholm L, Persson B, et al. Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma. Br Med J 1984; 288: 1479–1482
   PubMed Web of Science ®Google Scholar
• McGee J OD, Woods J C, Ashall F, et al. Immunohistochemi-cal detection of the Ca antigen in human tissues with the Calantibody. Lancet 1982; 11: 7–10
   Google Scholar
• Bramwell M E, Ghosh A K, Smith W D, et al. Ca2 and Ca2: New monoclonal antibodies evaluated as tumor markers on serous effusions. Cancer, in press
   Google Scholar
• Holyoke E D, Chu T M, Evans J, . Biochemical Markers for Cancer, T M Chu, et al. Marcel Dekker, New York 1982; 61–80
   Google Scholar
• Vincent R G, Chu T M, Lane W W. The value of carcinoembryonic antigen with carcinoma of the lung. Cancer 1979; 44: 685–691
   PubMed Web of Science ®Google Scholar
• Killian C S, Vargas F P, Pontes J E, et al. The use of serum isoenzymes of alkaline and acid phosphatase as possible quantitative markers for tumor load in prostate cancer. Prostate 1981; 2: 198–206
   Google Scholar
• Moore T L, Dhar P, Zamcheck N, et al. Carcinoembryonic antigen in liver disease. Gastroenterology 1972; 63: 88–94
   PubMed Web of Science ®Google Scholar
• Greene G L, Jensen E V. Monoclonal antibodies as probes for estrogen receptor detection and characterization. J Steroid Biochem 1982; 16: 353–359
   PubMedGoogle Scholar
• Witliff J J, Leinen P A, Mehta R G, . Steroid-receptor interactions in normal and neoplastic mammary tissues. Biochemical Markers for Cancer, T M Chu, et al. Marcel Dekker, New York 1982; 183–228
   Google Scholar
• Logeat F, Hai M T, Milgrom E. Antibodies to rabbit progesterone receptor: Cross reaction with human receptor. Proc Natl Acad Sci USA 1981; 78: 1426–1430
   PubMed Web of Science ®Google Scholar
• Radanyi C, Joab I, Renoir J M, et al. Monoclonal antibody to chicken oviduct progesterone receptor. Proc Natl Acad Sci USA 1983; 80: 2854–2858
   PubMed Web of Science ®Google Scholar
• Hsu S M, Raine L, Fanger H. The use of avidin-biotin-perox-idase complex in immunoperoxidase techniques. J Histochem Cytochem 1981; 29: 577–581
   PubMed Web of Science ®Google Scholar
• Greaves M F. “Target” cells, cellular phenotypes and lineage fidelity in human leukemia. J Cell Physiol 1982; 1(Suppl)113–125
   Google Scholar
• Nadler L M, Ritz J., Hardy R, et al. A unique cell surface antigen identifying lymphoid malignancies of B cell origin. J Clin Invest 1981; 67: 134–148
   PubMed Web of Science ®Google Scholar
• Greene G L, Nolan C, Engler J P, et al. Monoclonal antibodies to human estrogen receptor. Proc Natl Acad Sci USA 1980; 77: 5115–5119
   PubMed Web of Science ®Google Scholar
• King W J, Greene G L. Monoclonal antibodies localize estrogen receptor in the nuclei of target cells. Nature 1984; 307: 745–747
   PubMed Web of Science ®Google Scholar
• Loor R M, Shimano T, Manzo M L, et al. Purification and characterization of a human pancreas specific antigen. Bio-chim Biophys Acta 1981; 668: 222–234
   PubMed Web of Science ®Google Scholar
• Shochat D, Archey D L, Pant K D, et al. Characterization of colon-specific antigen-p and isolation of immunologically active tryptic peptides. J Immunol 1981; 126: 2284–2289
   PubMed Web of Science ®Google Scholar
• Wang M C, Kuriyama M, Papsidero L D, . Prostate antigen of human cancer patients. Methods in Cancer Research XIX, H Busch, L C Yeoman, et al. Academic Press, New York 1982; 179–197
   Google Scholar
• Foster C S, Edwards P AW, Dinsdale E A, et al. Monoclonal antibodies to the human mammary gland. Virchows Arch Pathol Anat Physiol Clin Med 1982; 394: 279–293
   PubMed Web of Science ®Google Scholar
• Nadji M, Tabei S Z, Castro A, et al. Prostate specific antigen, an immunohistologic marker for prostate neoplasms. Cancer 1981; 48: 1229–1232
   PubMed Web of Science ®Google Scholar
• Szpak C A, Johnston W W, Lottich SC, et al. Patterns of reactivity of four novel monoclonal antibodies with cells in human malignant and benign effusions. Acta Cytologica 1984; 28: 356–367
   PubMed Web of Science ®Google Scholar
• Croghan G A, Wingate M B, Gamarra M, et al. Reactivity of monoclonal antibody F36/22 with human ovarian adenocarcinomas. Cancer Res 1984; 44: 1954–1962
   PubMed Web of Science ®Google Scholar
• Pressman D. The development and use of radiolabeled antitumor antibodies. Cancer Res 1980; 40: 2960–2964
   PubMed Web of Science ®Google Scholar
• Goldenberg D, Deland F H, Kim E E, et al. Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. New Engl J Med 1978; 298: 1384–1388
   PubMed Web of Science ®Google Scholar
• Bale W F, Contreras M A, Grady E D. Factors influencing localization of labeled antibodies in tumors. Cancer Res 1980; 40: 2965–2972
   PubMed Web of Science ®Google Scholar
• Goldenberg D M, Kim E E, Deland F H, et al. Clinical studies on the radioimmunodetection of tumors containing α-fetopro-tein. Cancer 1980; 45: 2500–2505
   PubMed Web of Science ®Google Scholar
• Goldenberg D M, Kim F E, Deland F H. Human chorionic gonadotropin radioantibodies in the radioimmunodetection of cancer and for disclosure of occult metastases. Proc Natl Acad Sci USA 1981; 78: 7754–7758
   PubMed Web of Science ®Google Scholar
• Primus F J, Deland F H, Goldenberg D M, . Monoclonal antibodies for radioimmunodetection of cancer. Monoclonal Antibodies and Cancer, G L Wright, et al. Marcel Dekker, New York 1984; 305–323
   Google Scholar
• Moshakis V, Ormerod M G, Westwood J H, et al. The site of binding of anti-CEA antibodies to tumor CEA in vivo. Br J Cancer 1982; 46: 18–21
   PubMed Web of Science ®Google Scholar
• Rainbury R, Westwood J. Tumor localization with monoclonal antibody radioactively labeled with metal chelate rather than iodine. Lancet 1982; 11: 1347–1348
   Google Scholar
• Scheinberg D A, Strand M, Ganson O A. Tumor imaging with radioactive metal chelates conjugated to monoclonal antibodies. Science 1982; 215: 1511–1513
   PubMed Web of Science ®Google Scholar
• Hnatowich D J, Layne W W, Lanteigne D, et al. Radioactive labeling of antibody: A simple and efficient method. Science 1983; 220: 613–615
   PubMed Web of Science ®Google Scholar
• Fairweather D S, Bradwell A R, Dykes P W. Labeled antibodies for tumor localization. Lancet 1983; 1: 367–368
   PubMed Web of Science ®Google Scholar
• Lee C L, Kawinski E, Leong S S, et al. Radioimmunodetection and immunochemotherapy of xenografted human prostatic tumor using monoclonal antibodies. Fed Proc 1983; 42: 682
   Google Scholar
• Williams L E. The importance of traditional methods of measuring tracer biodistributions. Cancer Res 1984; 44: 2731–2732
   PubMed Web of Science ®Google Scholar
• Hedin A, Wahren B, Hammarstrom S. Tumor localization of CEA-containing human tumors in nude mice by means of monoclonal anti-CEA antibodies. Br J Cancer 1982; 30: 547–552
   Web of Science ®Google Scholar
• Dillman R O, Witztum K, Dillman J B, et al. Radioimmunodetection with indium-conjugated monoclonal antibodies. Proc Am Assoc Cancer Res 1984; 25: 248
   Web of Science ®Google Scholar
• Farrands P A, Perkins A C, Pimm M V, et al. Radioimmunodetection of human colorectal cancer by an antitumor monoclonal antibody. Lancet 1982; 11: 397–400
   Google Scholar
• Mach J P, Chatal J F, Lumbroso J D, et al. Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma. Cancer Res 1983; 43: 5593–5600
   PubMed Web of Science ®Google Scholar
• Moldofsky P J, Sears H F, Mulhern C B, et al. Detection of metastatic tumor in normal-sized retroperitoneal lymph nodes by monoclonal antibody imaging. New Engl J Med 1984; 311: 106–107
   PubMed Web of Science ®Google Scholar
• Bradwell A R, Vaughan A, Fairweather D S, et al. Improved radioimmunodetection of tumors using second antibody. Lancet 1983; 1: 247
   PubMed Web of Science ®Google Scholar
• Sharkey R M, Primus F J, Goldenberg D M. Improved radioimmunodetection of tumors by second antibody. Proc Am Assoc Cancer Res 1984; 25: 252
   Web of Science ®Google Scholar
• Mizusawa E., Dahlan H L, Benett S J, et al. Neutron-capture therapy of human cancer: In vitro results or the preparation of boron-labeled antibodies to carcinoembryonic antigen. Proc Natl Acad Sci USA 1982; 79: 3011–3014
   PubMed Web of Science ®Google Scholar
• Goldenberg D M, Sharkey R M, Primus F J, et al. Neutron-capture therapy of human cancer: In vivo results on tumor localization of boron-10-labeled antibodies to carcinoembryonic antigen in GW-39 tumor model system. Proc Natl Acad Sci USA 1984; 81: 560–563
   PubMed Web of Science ®Google Scholar
• Kuchel P W. Nuclear magnetic resonance of biological samples. CRC Crit Rev Anal Chem Oct 1981; 155–231
   Google Scholar
• Mastrangelo M J, Berd D B, Maguire H C. Current condition and prognosis of tumor immunotherapy. Cancer Treatment Reports 1984; 68: 207–219
   PubMedGoogle Scholar
• Editorial. Antigenic modulation and monoclonal antibodies in leukemia and lymphoma. Lancet 1982; 1: 1054–1056
   PubMedGoogle Scholar
• Capone P M, Papsidero L D, Croghan G A, et al. Experimental tumoridical effects of monoclonal antibody against solid breast tumors. Proc Natl Acad Sci USA 1983; 80: 7328–7332
   PubMed Web of Science ®Google Scholar
• Yachi A, Imai K, Higashide T, et al. Therapeutic approach of the monoclonal antibodies to human tumor associated antigens. Proc Int Soc Oncodev Biol Med 1984, Abs.#4
   Google Scholar
• Waldmann H, Polliak A, Hale G, et al. Elimination of graft-versus-host disease by in vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody. Lancet 1984; 11: 483–486
   Google Scholar
• Nadler L M, Takvorian T, Botnick L, et al. Anti-B1 monoclonal antibody and complement treatment in autologous bone-marrow transplantation for relapsed B-cell non-Hodgkin's lymphoma. Lancet 1984; 11: 427–430
   Google Scholar
• Buckman R, McLlhinney R AJ, Shepherd V, et al. Elimination of carcinoma cells from human bone marrow. Lancet 1982; 11: 1428–1430
   Google Scholar
• Treleaven J G, Gibson F M, Ugelstad J, et al. Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres. Lancet 1984; 1: 70–73
   PubMed Web of Science ®Google Scholar
• Order S E, Ettinger D, Klein J, et al. Radiolabeled antibodies in the treatment of hepatic malignancies. Int J Radiother Oncol Biol Phys 1982; 8(Suppl. I)121
   PubMedGoogle Scholar
• Order S E. Hodgkin's, liver, lung all on radiolabeled antibody trials. Oncology Times April 1984; 10, 36
   Google Scholar
• Hammersmith Oncology Group & Imperial Cancer Research Fund. Antibody-guided irradiation of malignant lesions. Lancet 1984; I: 1441–1443
   Google Scholar
• Embleton M J, Rowland G F, Simmonds R G, et al. Selective cytotoxicity against human tumor cells by a vindesine-mono-clonal antibody conjugate. Br J Cancer 1983; 47: 43–49
   PubMed Web of Science ®Google Scholar
• Arnon R, Rela M. In vitro and in vivo efficacy of conjugates of daunomycin with anti-tumor antibodies. Immunol Rev 1982; 62: 5–27
   PubMed Web of Science ®Google Scholar
• Lee C L, Chu T M, unpublished results
   Google Scholar
• Uadia P, Blair A H, Ghose T. uptake of methotrexate to an anti-EL-4 lymphoma antibody by EL4 cells. Cancer Immunol Immunother 1983; 16: 127–129
   PubMed Web of Science ®Google Scholar
• Hurwitz E, Levy R, Maron R, et al. The covalent binding of duanomycin and adriamycin to antigen with retention of both drug and antibody activities. Cancer Res 1975; 35: 1175–1181
   PubMed Web of Science ®Google Scholar
• Vitatta E S, Krolick K A, Miyama-Inaba M, et al. Immu-notoxin: A new approach to cancer therapy. Science 1983; 219: 644–650
   PubMed Web of Science ®Google Scholar
• Ash R C, Zanjani E D, Kersey J H, et al. Anti-T-cell reagents for human bone marrow transplantation: Ricin linked to three monoclonal antibodies. Science 1983; 222: 512–514
   PubMed Web of Science ®Google Scholar
• Steplewski Z, Lubeck M D, Koprowski H. Human macrophages armed with murine immunoglobulin G2a antibodies to tumor destroy human cancer cells. Science 1983; 221: 865–867
   PubMed Web of Science ®Google Scholar
• Ritz J., Pesando J M, Sallan S E, et al. Serotherapy of acute lymphoblastic leukemia with monoclonal antibody. Blood 1981; 58: 141–152
   PubMed Web of Science ®Google Scholar
• Levy R, Miller R EA. Tumor therapy with monoclonal antibodies. Fed Proc 1983; 42: 2650–2656
   PubMedGoogle Scholar
• Koprowski H, Herlyn D, Lubeck M, et al. Human antiidiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient?. Proc Natl Acad Sci USA 1984; 81: 216–219
   PubMed Web of Science ®Google Scholar
• Miller R A, Maloney D G, Warnke R, et al. Treatment of B cell lymphoma with monoclonal anti-idiotype antibody. New Engl J Med 1982; 306: 517–522
   PubMed Web of Science ®Google Scholar
• Sears H F, Atkinson B, Mattis J, et al. Phase-I clinical trial of monoclonal antibody in treatment of gastrointestinal tumors. Lancet 1982; 1: 762–765
   PubMed Web of Science ®Google Scholar
• Gill G N, Kawamoto T, Cochet C, et al. Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity. J Biol Chem 1984; 259: 7755–7760
   PubMed Web of Science ®Google Scholar